The global polyclonal antibodies market is poised for substantial growth, fueled by increasing applications in diagnostics, therapeutics, and research. Recent estimations place the market size at USD 1.7 billion in 2022, with projections indicating a significant expansion to USD 2.5 billion by 2030. This growth trajectory represents a steady Compound Annual Growth Rate (CAGR) of 5.1%...